Join Parexel experts as they discuss lessons learned over the past three months in managing COVID-19’s impact on trials in China. Strategies and tactics for ensuring patient safety and keeping trials moving forward despite severe travel restrictions will be detailed. Our panel will provide insights into what companies should be doing now to prepare for the upcoming ‘new normal’ and what longer-term changes are likely to occur because of the pandemic – and the opportunities and challenges these changes present.
Chang Q. Lee, M.D., MSHA, Dr.PH FCAP
Vice President, Consulting & Access APAC
Licensed Physician and Board-certified pathologist in the US. 6 years at the CDER/FDA. Former Executive in many pharma companies. Leading clinical research and regulatory affairs for global programs. Based in US/China and responsible for APAC regulatory teams.
Vice President, Head of Biotech Operations APAC
Currently leading APAC biotech operations teams in managing studies/programs globally and lead operations strategic planning activities and translate strategic decision into actionable operational plans. Extensive experience in early and late phase development in multiple therapeutic areas. Her background includes leadership roles in clinical research, project/portfolio management, regulatory etc along with extensive clinical operations experience in pharmaceutical and CRO industries.
Senior Director, Clinical Operations, China
Master’s in molecular biology. More than 15 years experiences in clinical trials from Phase I to Phase IV. Deep understanding on China clinical trial environment with operational excellence.
Senior Director, Data operation, APAC
Regional Head of Biostatistics and Statistical Programming in Parexel, hands on end to end from study design to regulatory submissions. Actively contributed to NMPA guideline development as industry representatives.
Jeff Ten PMP
Director (APAC) Project Management and Delivery, Clinical Trial Supplies & Logistics
Over 15 years of progressive experience in health science and Clinical Research Industry. Currently oversees and lead the Operation for Clinical Trial Supplies and Logistics in Asia Pacific. Where we strategize, design and execute the sourcing, packaging, labelling and distribution of Clinical Trial materials.
Director, Clinical Operations, APAC
Director, Integrated Solution Consultant